There is still a lot of uncertainty about the rollout of a COVID-19 vaccine in Europe, but it now seems likely that it will be delivered to those most vulnerable to the disease by Q2 next year, which would help to reduce the risk of damaging runs on healthcare systems. This could allow governments to start to lift the majority of restrictions during the spring, and to put economic activity on a path back to normality.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.